Pan Du

9.4k citations
63 papers · 7.6k · 5 hit papers · h-index 32

Impact in

  • Cancer Research top 2%
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies
  • Molecular Biology top 2%
    • Epigenetics and DNA Methylation
    • Gene expression and cancer classification
    • Bioinformatics and Genomic Networks

Papers in

  • Cancer Research 12
    • Cancer Genomics and Diagnostics 9
  • Molecular Biology 22
    • Epigenetics and DNA Methylation 8
    • Gene expression and cancer classification 7
    • Biomedical Text Mining and Ontologies 3
    • Bioinformatics and Genomic Networks 3
Co-authors
Warren A. Kibbe (13 shared papers)Simon M. Lin (22 shared papers)Simon M. Lin (5 shared papers)Nadereh Jafari (6 shared papers)Lifang Hou (5 shared papers)Chiang‐Ching Huang (4 shared papers)Xiao Zhang (1 shared paper)Wolfgang Huber (1 shared paper)
Journals
Clinical Cancer Research (5 papers)PLoS ONE (4 papers)Bioinformatics (3 papers)European Urology (3 papers)EBioMedicine (3 papers)
Partner nations
United StatesChinaAustralia

In The Last Decade

Pan Du

62 papers receiving 7.5k citations

Pan Du's Hit Papers

Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells 2014 · 480 citations
4800+6+13Years since publication5001k1.5k
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2014 Cancer Cell
  2. 2010 Nature Biotechnology
  3. 2010 BMC Bioinformatics
  4. 2008 Bioinformatics
  5. 2006 Bioinformatics

Peers

Pan Du
Comparison fields: 5 of 169
  • Cancer Research 730
  • Molecular Biology 3.3k
  • Oncology 658
  • Pulmonary and Respiratory Medicine 630
  • Genetics 170
Replace Max Franz with:
Max Franz Canada
Anil Goud Jegga United States
Cheng Zhang Sweden
Sunjae Lee South Korea
Jian‐Hua Mao United States
Naigong Zhang United States
Johannes Haybaeck Austria
Bin Zhou China
Katherine Phillippy United States
Maxim Tomashevsky United States
Pan Du relative to Max Franz Canada Max Franz's profile →
Citations per field
00.5×1.5×1.8×
Max Franz · 1×
Citations per year

Countries citing papers authored by Pan Du

Since Specialization
Citations

This map shows the geographic impact of Pan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Du more than expected).

Fields of papers citing papers by Pan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Du. The network helps show where Pan Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Pan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pan Du Line = papers co-authored together Pan Du links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1
lumi : a pipeline for processing Illumina microarray
Bioinformatics ·Pan Du, Warren A. Kibbe, Simon M. Lin
Hit paper breakdown →		20081773
2
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
BMC Bioinformatics ·Pan Du, Xiao Zhang, Chiang‐Ching Huang, Nadereh Jafari, Warren A. Kibbe, Lifang Hou, Simon M. Lin
Hit paper breakdown →		20101585
3
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Nature Biotechnology ·Leming M. Shi, Zhining Wen, Minjun Chen, Huixiao Hong, Roger Perkins, James C. Fuscoe, Weigong Ge, Stephen Harris
Hit paper breakdown →		2010711
4
Improved peak detection in mass spectrum by incorporating continuous wavelet transform-based pattern matching
Bioinformatics ·Pan Du, Warren A. Kibbe, Simon M. Lin
Hit paper breakdown →		2006598
5
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Cancer Cell ·Ho-June Lee, Guanglei Zhuang, Yi Cao, Pan Du, Hyojin Kim, Jeff Settleman
Hit paper breakdown →		2014480
6
Model-based variance-stabilizing transformation for Illumina microarray data
Nucleic Acids Research ·Simon M. Lin, Pan Du, Wolfgang Huber, Warren A. Kibbe
2008444
7
Genome-Wide DNA Methylation Indicates Silencing of Tumor Suppressor Genes in Uterine Leiomyoma
PLoS ONE ·Ping Yin, Diana Monsivais, Simon M. Lin, Pan Du, Jian‐Jun Wei, Serdar Ekrem Bulun +1 other
2012112
8
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
Nature Communications ·Daniel John Renouf, Jonathan Loree, Jennifer Jane Knox, James Thomas Topham, Petr Kavan, Derek J. Jonker, Stephen A. Welch, Félix Couture
2022111
9
Diverse modes of genomic alteration in hepatocellular carcinoma
Genome biology ·Suchit Jhunjhunwala, Zhaoshi Jiang, Eric W. Stawiski, Florian Gnad, Jinfeng Liu, Oleg Mayba, Pan Du, Jingyu Diao
2014107
10
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
EBioMedicine ·Manish Kohli, Winston W. Tan, Tiantian Zheng, Amy Wang, Carlos Montesinos, Calven Wong, Pan Du, Shidong Jia
2020107
11
Genomics of Human Intracranial Aneurysm Wall
Stroke ·Changbin Shi, Issam A. Awad, Nadereh Jafari, Simon M. Lin, Pan Du, Ziad A. Hage, Robert Shenkar, Christopher C. Getch
2009104
12
From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations
Bioinformatics ·Pan Du, Gang Feng, Jared M. Flatow, Jie Young Song, Michelle Holko, Warren A. Kibbe, Simon M. Lin
200993
13
The Early Growth Response Gene Egr2 (Alias Krox20) Is a Novel Transcriptional Target of Transforming Growth Factor-β that Is Up-Regulated in Systemic Sclerosis and Mediates Profibrotic Responses
American Journal Of Pathology ·Feng Fang, Kohtaro Ooka, Swati Bhattachyya, Jun Wei, Minghua Wu, Pan Du, Simon M. Lin, Francesco Del Galdo
201180
14
nuID: a universal naming scheme of oligonucleotides for Illumina, Affymetrix, and other microarrays
Biology Direct ·Pan Du, Warren A. Kibbe, Simon M. Lin
200776
15
DNA methylation alterations in response to pesticide exposure in vitro
Environmental and Molecular Mutagenesis ·Xiao Zhang, Andrew D. Wallace, Pan Du, Warren A. Kibbe, Nadereh Jafari, Hehuang Xie, Simon M. Lin, Andrea Baccarelli
201273
16
DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer
Clinical Cancer Research ·Walter Kim, Thomas Holcomb, Tom Januario, Pan Du, Marie Evangelista, Nithya Kartha, Leonardo A. Iniguez, Robert H. Soriano
201273
17
Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors
Clinical Cancer Research ·David S. Shames, Kristi Elkins, Kimberly Walter, Thomas Holcomb, Pan Du, Dane A. Mohl, Yang Xiao, Thinh Pham
201372
18
Expression of Cyclophilin B is Associated with Malignant Progression and Regulation of Genes Implicated in the Pathogenesis of Breast Cancer
American Journal Of Pathology ·Feng Fang, Ayanna J. Flegler, Pan Du, Simon M. Lin, Charles V. Clevenger
200866
19
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial
European Urology ·Edmond M. Kwan, Lavinia Anne Spain, Angelyn Anton, Chun Loo Gan, Deborah Chang, Elizabeth Chien Hern Liow, Caitlin Bennett, Tiantian Zheng
202160
20
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer
European Urology ·Heidi Fettke, Edmond M. Kwan, Maria M. Docanto, Patricia E. Bukczynska, Nicole Ng, Lisa-Jane K. Graham, Kate Lynette Mahon, Christine Hauser
202056

About Pan Du

Pan Du is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Ophthalmology and Oncology, having authored 63 papers that have together received 7.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer Genomics and Diagnostics (9 papers), Epigenetics and DNA Methylation (8 papers), Gene expression and cancer classification (7 papers), Glaucoma and retinal disorders (4 papers), Biomedical Text Mining and Ontologies (3 papers), Bioinformatics and Genomic Networks (3 papers) and Advanced Proteomics Techniques and Applications (3 papers). The work is most often cited by research in Cancer Research (730 citations), Molecular Biology (3.3k citations), Oncology (658 citations), Pulmonary and Respiratory Medicine (630 citations) and Genetics (170 citations). Pan Du has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Warren A. Kibbe, Simon M. Lin, Simon M. Lin, Nadereh Jafari, Lifang Hou, Chiang‐Ching Huang, Xiao Zhang, Wolfgang Huber, Guanglei Zhuang and Jeff Settleman. Their work appears in journals such as Clinical Cancer Research, PLoS ONE, Bioinformatics, European Urology and EBioMedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Max FranzBreakdown of academic impact, for papers by Anil Goud JeggaBreakdown of academic impact, for papers by Cheng ZhangBreakdown of academic impact, for papers by Sunjae LeeBreakdown of academic impact, for papers by Jian‐Hua MaoBreakdown of academic impact, for papers by Naigong ZhangBreakdown of academic impact, for papers by Johannes HaybaeckBreakdown of academic impact, for papers by Bin ZhouBreakdown of academic impact, for papers by Katherine PhillippyBreakdown of academic impact, for papers by Maxim Tomashevsky